| Literature DB >> 33342697 |
Alda Linhares de Freitas Borges1, Pauliana Lamounier E Silva Duarte1, Rodolfo Bonfim Siqueira de Almeida1, Alleluia Lima Losno Ledesma1, Yaná Jinkings de Azevedo1, Larissa Vilela Pereira1, Fayez Bahmad2.
Abstract
INTRODUCTION: Tinnitus is a frequent symptom in cochlear implant patients, often reported as persistent and disabling in implant candidates. Tinnitus is rarely considered in the preoperative evaluation of patients who are eligible for cochlear implantation. Many studies have shown that a cochlear implant leads to a significant change in the perception of tinnitus.Entities:
Keywords: Cochlear implant; Hearing loss; Tinnitus; Tinnitus perception
Mesh:
Year: 2020 PMID: 33342697 PMCID: PMC9422519 DOI: 10.1016/j.bjorl.2020.11.006
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Figure 1Diagram of the identification and selection of articles adapted from PRISMA.
Studies with patients meeting the inclusion criteria for meta-analysis.
| Study | Author | Type of study | Year | Location | Sample | Subjective outcomes for tinnitus | Study group | Age at cochlear implantation (mean) | Device | Type of procedure | Length of follow-up (mo) | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cochlear implantation as a long-term treatment for ipsilateral incapacitating tinnitus in subjects with unilateral hearing loss up to 10 years | Mertens G. et al. | Quasi-experimental-studies | 2015 | Belgium | 23 | TQ + VAS | SSD (profound) and AHL | 55 yr. | No information | Unilateral | 1 to 36 | Reduction in TQ scores (55 to 31 points) and on VAS (8 to 3 points) |
| Effect of cochlear implantation on quality of life in adults with unilateral hearing loss | Dillon M.T. et al. | Quasi-experimental studies | 2017 | USA | 20 | THI | SSD (moderate/profound) | 50 yr. (SD = 11.5) | MED-EL, concerto, standard electrode array | Unilateral | 12 to 48 | Reduction in THI scores (23.3 to 2.8 points), 90% reduction in THI scores |
| Effect of unilateral and simultaneous bilateral cochlear implantation on tinnitus: a prospective study | van Zon A. et al. | Quasi-experimental studies | 2016 | Multicentric | 38 | THI + TQ + VAS | NSHL (severe/profound) | 50.3 yr. (SD = 14.4) | Advanced Bionics HiRes90 K | Unilateral and Bilateral (simulta neous) | 48 | Reduction in THI scores (13 to 3 points) and TQ (17 to 7 points) and VAS (5 to 2), 80% reduction in THI scores |
| On the necessity of full length electrical cochlear stimulation to suppress severe tinnitus in single-sided deafness | Punte A.K. et al. | Quasi-experimental studies | 2013 | Belgium | 14 | TQ + VAS | SSD (profound) | No information | MED-EL Sonata TI 100 | Unilateral | 6 | Reduction in TQ scores (60 to 39 points) and VAS (8.2 to 4.1 points), 85.7% reduction in TQ scores and 100% on VAS scores |
| Self-reported benefits from successive bilateral cochlear implantation in postlingually deafened adults: randomized controlled trial | Quentin Summerfield A. et al. | Randomized controlled trial | 2006 | Multicentric | 24 | VAS own questionnaire | NSHL (profound) | No information | Cochlear Nucleus CI-24 | Unilateral and bilateral (simultaneous and sequential) | 3 to 22 | Reduction in tinnitus perception and annoyance |
| Suppression of tinnitus in chinese patients receiving regular cochlear implant programming | Liu Y. et al. | Randomized controlled trial | 2015 | China | 234 | THI | NSHL (profound) | 28.6 yr. | Cochlear Nucleus 24 | Unilateral | 1 to 30 | Reduction in THI scores in all patients |
| the impact of cochlear implantation on speech understanding, subjective hearing performance, and tinnitus perception in patients with unilateral severe to profound hearing loss | Távora-Vieira D. et al. | Quasi-experimental studies | 2015 | Australia | 28 | TRQ | SSD (severe/ profound) | 53.75 yr. | MED-EL GmbH | Unilateral | 3 to 24 | Reduction in TRQ scores (48.8 to 1.75 points) |
| Tinnitus after simultaneous and sequential bilateral cochlear implantation | Ramakers G.G.J. et al. | Quasi-experimental studies | 2017 | Netherlands | 38 | THI + TQ | NSHL (moderate/profound) | No information | Advanced Bionics HiRes90 K | Bilateral (simultaneous/sequential) | 12 to 144 | Reduction THI scores (13 to 5) and TQ (17 to 7 points), 62% reduction in THI scores |
| Tinnitus modifications after cochlear implantation | Di Nardo W. et al. | Quasi-experimental studies | 2007 | Italy | 30 | THI | NSHL (severe/ profound) | 39.17 yr. (SD = 16.49) | Cochlear, Digisonic MSM, Clarion, MED-EL, COMBI-40 + MED-EL | No Information | 24 | Reduction in THI scores (44,5 to 25 points), 65% reduction in THI scores |
| Tinnitus suppression by intracochlear electrical stimulation in single-sided deafness: a prospective clinical trial - part I | Arts R.A. et al. | Quasi-experimental-studies | 2014 | Multicentric | 10 | THI + TQ + VAS | SSD (moderate/severe) | 48.2 yr. (SD = 12.6) | MED-EL, Concerto, OPUS2, Maestro version 4.1.2 | Unilateral | 1 to 8 | Reduction in THI scores (45 to 31 points), TQ (41 to 26 points) and VAS (7.1 to 4.3 points), 70% reduction in THI scores |
| Tinnitus suppression by intracochlear electrical stimulation in single-sided deafness - a prospective clinical trial: follow-up | Arts R.A. et al | Quasi-experimental studies | 2015 | Multicentric | 10 | THI + TQ + VAS | SSD (moderate/severe) | 48.2 yr. | MED-EL, Concerto, OPUS2, Maestro version 4.1.2 | Unilateral | 1 to 12 | Reduction in THI scores (45 to 31 points), TQ (40 to 30 points) and VAS (7.1 to 2.8 points), 80% reduction in THI scores |
TQ, Tinnitus questionnaire; VAS, Visual qnalog scale; THI, Tinnitus handicap inventory; TRQ, Tinnitus reaction questionnaire.
The 10 patients analyzed in Part I of the Remo Arts study were the same as those analyzed in the follow-up but at different times after CI activation.
Articles eligible for meta-analysis.
Quality Assessment of the studies based on directness category.
| Study | Type of study | Sample | Patients (with SHL, uni or bilateral) | Therapy (IC uni or bilateral) | Outcome (evaluation of tinnitus perception after implantation) | Follow-up (≥ 6 months) | DoE |
|---|---|---|---|---|---|---|---|
| Mertens G. et al. | PCS | 23 | (+) | (+) | (+) | (+) | H |
| Dillon M.T. et al. | PCS | 20 | (+) | (+) | (+) | (+) | H |
| van Zon A. et al. | RCT | 38 | (+) | (+) | (+) | (+) | H |
| Punte A.K. et al. | PCS | 14 | (+) | (+) | (+) | (-) | M |
| Quentin Summerfield A. et al. | RCT | 24 | (+) | (+) | (+) | (-) | M |
| Liu Y. et al. | RCT | 234 | (+) | (+) | (+) | (+) | H |
| Távora-Vieira D. et al. | PCS | 28 | (+) | (+) | (+) | (+) | H |
| Ramakers G.G.J. et al. | RCT | 38 | (+) | (+) | (+) | (+) | H |
| Di Nardo W. et al. | PCS | 30 | (+) | (-) | (+) | (+) | M |
| Arts R.A. et al. | PCS | 10 | (+) | (+) | (+) | (-) | M |
| Arts R.A. et al. | RCS | 10 | (+) | (+) | (+) | (-) | M |
DoE, Directness of evidence; H, High; M, Moderate; PCS, Prospective case series; RCS, Retrospective case series; RCT, Randomized Controlled Trial.
Level of directness of evidence: A high directness of evidence was defined as a positive score on all criteria, moderate as a positive score on three out of the four criteria, and a low directness of evidence if they complied with less than three criteria.
JBI Critical appraisal checklist for quasi-experimental studies.
| Arts R.A. et al. | Arts R.A. et al. | Dillon M.T. et al. | Geerte G.J. et al. | Di Nardo W. et al. | Mertens G. et al. | Punte A.K. et al. | Távora-Vieira D. et al. | |
|---|---|---|---|---|---|---|---|---|
| Is it clear in the study what is the “cause” and what is the “effect”? | Y | Y | Y | Y | Y | Y | Y | Y |
| Were the participants included in any comparisons similar? | Y | Y | Y | Y | Y | Y | Y | Y |
| Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest? | Y | Y | Y | Y | Y | Y | Y | Y |
| Was there a control group? | N | N | N | N | Y | N | Y | N |
| Were there multiple measurements of the outcome both pre and post the intervention/exposure? | Y | Y | Y | Y | Y | Y | Y | Y |
| Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed? | Y | Y | Y | Y | Y | Y | Y | Y |
| Were the outcomes of participants included in any comparisons measured in the same way? | Y | Y | Y | N | Y | Y | Y | Y |
| Were outcomes measured in a reliable way? | Y | Y | Y | Y | Y | Y | Y | Y |
| Was appropriate statistical analysis used? | Y | Y | Y | Y | Y | Y | Y | Y |
| Bias risk (%) | 88,88% | 88,88% | 88,88% | 77,77% | 100% | 88,88% | 100% | 88,88% |
JBI Critical appraisal checklist for randomized controlled trials.
| van Zon A. et al. | Quentin Summerfield A. et al. | Liu Y. et al. | |
|---|---|---|---|
| Was true randomization used for assigning participants to treatment groups? | Y | Y | Y |
| Was allocation to treatment groups concealed? | Y | Y | Y |
| Were treatment groups similar at the baseline? | Y | Y | Y |
| Were participants blind to treatment assignment? | NA | NA | NA |
| Were those delivering treatment blind to treatment assignment? | NA | NA | NA |
| Were outcomes assessors blind to treatment assignment? | NA | NA | NA |
| Were treatment groups treated identically other than the intervention of interest? | Y | Y | Y |
| Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed? | Y | Y | Y |
| Were participants analyzed in the groups to which they were randomized? | Y | Y | Y |
| Were outcomes measured in the same way for treatment groups? | Y | Y | Y |
| Were outcomes measured in a reliable way? | Y | Y | Y |
| Was appropriate statistical analysis used? | Y | Y | Y |
| Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? | Y | Y | Y |
| Bias risk (%) | 90% | 90% | 90% |
Meta-analysis estimates of cochlear implantation on the Tinnitus Handicap Inventory score. The mean summary difference across the studies indicated an 11.66-point reduction in the tinnitus severity score (95% CI 5.67 to 17.65; p < 0.001). There was marked heterogeneity between the studies (I2 = 96.4%).
| Study | Mean differences | 95% CI | Weight (%) |
|---|---|---|---|
| 1. Arts R.A. et al. | 12.50 | 8.16; 16.84 | 13.87 |
| 2. Arts R.A. et al. | 17.10 | 13.17; 21.03 | 14.06 |
| 3. Dillon M.T. et al. | 18.15 | 16.11; 20.19 | 14.71 |
| 4. Ramakers G.G.J. et al. | -3.07 | -6.07; -0.06 | 14.42 |
| 5. Ramakers G.G.J. et al. | 6.44 | 4.07; 8.82 | 14.62 |
| 6. Di Nardo W. et al. | 19.50 | 14.99; 24.01 | 13.79 |
| 7. van Zon A. et al. | 11.46 | 8.77; 14.15 | 14.53 |
| Global | 11.66 | 5.67; 17.65 | 100.00 |
Heterogeneity (p-value < 0.001); I2 = 96.4% of variation (randomized); global means test (p-value ≤ 0.001).
Figure 2Graphic summary of meta-analysis estimates of cochlear implantation on tinnitus handicap inventory score reduction after cochlear implantation.